메뉴 건너뛰기
European Journal of Cancer
Volumn 40, Issue 12, 2004, Pages 1872-1877
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
Author keywords

BBR3464; Gastric cancer; Phase II; Platinum complex
Indexed keywords

ANTIEMETIC AGENT; BBR 3464; LOPERAMIDE; PLATINUM COMPLEX;
EID: 3843077805     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.04.032     Document Type: Article
Times cited : (120)
References (9)
  • 1
    • 0000034627 scopus 로고    scopus 로고
    • A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumours
    • Calvert P.M., Highley M.S., Hughes A.N., et al. A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumours. Clin. Cancer Res. 5(Suppl. S):1999;333
    • (1999) Clin. Cancer Res. , vol.5 , Issue.SUPPL. S , pp. 333
    • Calvert, P.M.1    Highley, M.S.2    Hughes, A.N.3
  • 2
    • 50549174560 scopus 로고
    • The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent
    • Gehan E.A. The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent. J. Chron Dis. 13:1961;346-353
    • (1961) J. Chron Dis. , vol.13 , pp. 346-353
    • Gehan, E.A.1
  • 3
    • 0028016155 scopus 로고
    • A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
    • Findlay M., Cunningham D., Norman A., et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann. Oncol. 5(7):1994;609-616
    • (1994) Ann. Oncol. , vol.5 , Issue.7 , pp. 609-616
    • Findlay, M.1    Cunningham, D.2    Norman, A.3
  • 4
    • 0040366470 scopus 로고    scopus 로고
    • Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug
    • Kloster M.B., Hannis J.C., Muddiman D.C., Farrell N. Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug. Biochemistry. 38(45):1999;14731-14737
    • (1999) Biochemistry , vol.38 , Issue.45 , pp. 14731-14737
    • Kloster, M.B.1    Hannis, J.C.2    Muddiman, D.C.3    Farrell, N.4
  • 5
    • 0033035638 scopus 로고    scopus 로고
    • A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system
    • Perego P., Caserini C., Gatti L., et al. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol. Pharmacol. 55(3):1999;528-534
    • (1999) Mol. Pharmacol. , vol.55 , Issue.3 , pp. 528-534
    • Perego, P.1    Caserini, C.2    Gatti, L.3
  • 6
    • 0032788573 scopus 로고    scopus 로고
    • A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: Hypersensitivity of p53-mutant human tumour xenografts
    • Pratesi G., Perego P., Polizzi D., et al. A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. Br. J. Cancer. 80(12):1999;1912-1919
    • (1999) Br. J. Cancer. , vol.80 , Issue.12 , pp. 1912-1919
    • Pratesi, G.1    Perego, P.2    Polizzi, D.3
  • 7
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 92(3):2000;205-216
    • (2000) J. Natl. Cancer Inst. , vol.92 , Issue.3 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3
  • 8
    • 0031022803 scopus 로고    scopus 로고
    • Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
    • Webb A., Cunningham D., Scarffe J.H., et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J. Clin. Oncol. 15(1):1997;261-267
    • (1997) J. Clin. Oncol. , vol.15 , Issue.1 , pp. 261-267
    • Webb, A.1    Cunningham, D.2    Scarffe, J.H.3
  • 9
    • 0033802639 scopus 로고    scopus 로고
    • Clinical and pharmacological phase I study with accelerated titration design of a dialy times five schedule of BBR3464, a novel cationic triplatinum complex
    • Sessa C., Capri G., Gianni L., et al. Clinical and pharmacological phase I study with accelerated titration design of a dialy times five schedule of BBR3464, a novel cationic triplatinum complex. Ann. Oncol. 11(8):2000;977-983
    • (2000) Ann. Oncol. , vol.11 , Issue.8 , pp. 977-983
    • Sessa, C.1    Capri, G.2    Gianni, L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.